purpos
antigen
conjug
surfac
ntrimethylaminoethylmethacryl
chitosan
tmc
nanoparticl
induc
system
mucos
immun
respons
nasal
immun
method
tmc
synthes
free
radic
polymer
blank
nanoparticl
prepar
ionic
crosslink
tmc
sodium
tripolyphosph
model
antigen
ovalbumin
conjug
surfac
blank
nanoparticl
ovanp
thioester
bond
format
cellular
uptak
ovanp
investig
raw
macrophag
biodistribut
antigen
studi
radioiodin
label
method
immunolog
effect
evalu
nasal
administr
ovanp
balbc
mice
transport
mechan
nasal
toxic
ovanp
studi
rat
cellular
uptak
ovanp
significantli
higher
ovalbuminencapsul
nanoparticl
npe
min
nasal
administ
ovanp
show
higher
transport
antigen
cervic
lymph
node
higher
target
effici
group
compar
npe
ovanp
induc
much
higher
level
system
mucos
immun
respons
balbc
mice
three
nasal
immun
ex
vivo
cultur
nasopharynxassoci
lymphoid
tissu
nalt
confirm
particip
nasal
immun
transport
mechan
studi
reveal
ovanp
transport
across
nasal
epithelium
gland
may
taken
nalt
cell
ovanp
induc
obviou
toxic
nasal
mucosa
hemolysi
anim
present
studi
demonstr
conjug
tmc
nanoparticl
antigen
effect
strategi
nasal
vaccin
primari
method
protect
diseas
uptod
vaccin
via
intramuscular
subcutan
inject
play
outstand
role
evok
system
immun
respons
suffici
induc
mucos
antibodi
great
import
prevent
respiratori
infecti
diseas
suitabl
effect
vaccin
strategi
urgent
need
overcom
problem
nasal
vaccin
potenti
altern
intramuscular
vaccin
may
induc
system
mucos
immun
respons
nasal
mucosa
first
defens
infect
respiratori
pathogen
nasal
caviti
offer
sever
clear
advantag
vaccin
site
needlefre
applic
larg
mucos
surfac
vasculatur
rel
high
permeabl
abund
immunocompet
cell
rel
low
enzymat
activ
howev
major
drawback
nasal
vaccin
rel
poor
immunogen
free
antigen
compar
associ
intramuscular
vaccin
due
ineffici
antigen
deliveri
immun
system
via
nasal
caviti
therefor
vaccin
adjuv
carrier
nasal
immun
necessari
improv
immunogen
antigen
among
variou
carrier
report
quatern
chitosan
nanoparticl
one
success
exampl
bioadhes
quatern
chitosan
transitorili
open
tight
junction
nasal
epithelium
particl
smaller
easili
recogn
process
foreign
bodi
antigenpres
cell
apc
moreov
quatern
chitosan
enrich
posit
charg
interact
cell
allow
dissolv
water
wide
rang
ph
especi
physiolog
condit
result
good
permeat
enhanc
drug
deliveri
properti
thu
studi
synthes
quatern
deriv
chitosan
ntrimethylaminoethylmethacryl
chitosan
tmc
prepar
nanoparticl
nasal
vaccin
ovalbumin
ova
model
antigen
one
crucial
step
vaccin
antigen
contact
recogn
apc
howev
sever
factor
low
encapsul
effici
antigen
burst
releas
recognit
apc
may
weaken
role
antigenload
nanoparticl
nasal
vaccin
altern
approach
use
kind
nanoparticl
coval
conjug
antigen
surfac
nanoparticl
sloat
et
al
report
subcutan
immun
mice
antigenconjug
lecithinbas
nanoparticl
induc
quick
strong
durabl
function
immun
respons
possibl
due
abil
nanoparticl
facilit
uptak
antigen
apc
therebi
improv
traffick
antigen
local
drain
lymph
node
activ
apc
also
demonstr
antigen
link
inert
solid
nanobead
size
rang
nm
induc
high
level
antibodi
titr
cellmedi
immun
respons
protect
anim
tumor
cell
growth
pathogen
result
prove
conjug
antigen
nanoparticl
feasibl
method
immun
howev
best
knowledg
strategi
use
nasal
immun
consid
rel
low
enzymat
activ
nasal
caviti
may
result
slight
damag
antigen
expos
outsid
design
novel
antigenconjug
quatern
chitosan
nanoparticl
nasal
vaccin
compar
antigenencapsul
nanoparticl
nanoparticl
carrier
possess
follow
advantag
high
use
ratio
antigen
antigen
conjug
surfac
nanoparticl
easili
recogn
uptaken
apc
antigen
coval
conjug
nanoparticl
easili
detach
may
benefici
transport
antigen
immun
system
via
cervic
lymph
node
result
enhanc
mucos
system
immun
respons
test
hypothes
studi
tmc
synthes
free
radic
polymer
chitosan
ntrimethylaminoethylmethacryl
chlorid
tmc
nanoparticl
prepar
ionic
crosslink
tmc
sodium
tripolyphosph
ova
coval
conjug
surfac
nanoparticl
reaction
thiol
group
ova
maleimid
group
tmc
cellular
uptak
ovaconjug
nanoparticl
investig
raw
cell
distribut
lymph
node
nasal
instil
rat
also
track
ovaconjug
nanoparticl
administ
intranas
mice
evalu
immun
respons
nalt
isol
cultur
evalu
role
nasal
immun
safeti
ovanp
rat
also
assess
repeat
dose
chitosan
ammonium
persulf
ovalbumin
ova
hydrochlorid
obtain
sigma
usa
ntrimethylaminoethylmethacryl
chlorid
tmaemc
provid
fluka
switzerland
nsuccinimidyl
smp
purchas
adama
reagent
china
fluorescein
isocyan
fitc
bovin
serum
albumin
bsa
sodium
tripolyphosph
tpp
obtain
amresco
usa
goat
antimous
igg
hl
iga
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
fb
antirat
interleukin
elisa
kit
obtain
invitrogen
usa
bca
protein
assay
kit
reduc
glutathion
gsh
assay
kit
purchas
nanj
jiancheng
bioengin
compani
china
reagent
hplc
analyt
grade
raw
murin
macrophag
provid
cell
bank
type
cultur
collect
chines
academi
scienc
china
new
zealand
white
rabbit
male
kg
male
spraguedawley
rat
g
femal
balbc
mice
week
old
purchas
sinobritish
sipprbk
lab
anim
ltd
china
maintain
free
access
food
water
protocol
anim
experi
approv
anim
experiment
ethic
committe
fudan
univers
tmc
first
synthes
free
radic
polymer
chitosan
tmaemc
report
previous
briefli
low
molecular
weight
chitosan
g
react
tmaemc
g
ml
vv
acet
acid
h
g
ammonium
persulf
catalyst
tmc
purifi
dialyz
deioniz
water
use
cellulos
ester
membran
molecular
weight
cutoff
kda
h
tmc
incub
smp
g
h
room
temperatur
stir
dialyz
deioniz
water
h
reaction
product
maleimidetmc
collect
lyophil
tmc
maleimidetmc
character
previou
studi
prepar
character
tmc
nanoparticl
np
ovaconjug
tmc
nanoparticl
ovanp
ovaencapsul
tmc
nanoparticl
npe
np
prepar
ionic
crosslink
tmc
tpp
maleimidetmc
dissolv
mm
hepe
buffer
ph
contain
mm
nacl
concentr
mgml
equal
volum
tpp
mgml
drop
solut
magnet
stir
room
temperatur
stir
min
nanoparticl
collect
centrifug
min
glycerol
bed
use
model
centrifug
eppendorf
german
conjug
ova
tmc
nanoparticl
mg
ova
react
mg
h
ml
phosphat
buffer
solut
pb
ph
thiol
ova
purifi
desalt
column
ge
healthcar
sweden
hepe
buffer
eluent
ml
thiol
ova
mgml
mix
ml
tmc
nanoparticl
mgml
stir
min
ovanp
collect
centrifug
min
supernat
use
determin
unconjug
ova
fitclabel
ovanp
prepar
manner
describ
except
ova
replac
fitclabel
ova
npe
also
prepar
ionic
crosslink
method
except
ova
ad
maleimidetmc
solut
concentr
mgml
nanoparticl
collect
centrifug
supernat
use
determin
unload
ova
particl
size
zeta
potenti
nanoparticl
determin
use
nano
zetas
malvern
uk
structur
properti
nanoparticl
measur
use
scan
electron
microscop
sem
philip
netherland
ova
determin
sizeexclus
hplc
shimadzu
japan
tsk
gel
xl
column
mm
tosoh
japan
mobil
phase
phosphat
buffer
nah
po
na
wv
nan
ph
flow
rate
mlmin
wavelength
nm
conjug
effici
encapsul
effici
ova
calcul
indic
vitro
releas
npe
carri
pb
shake
rpm
differ
time
point
three
sampl
centrifug
min
supernat
use
determin
ova
releas
npe
vitro
uptak
ovanp
raw
cell
raw
cell
cultur
dmem
supplement
fb
seed
onto
glassbottom
dish
vitro
scientif
usa
densiti
cellscm
cultur
co
cell
incub
fitclabel
free
ova
ovanp
npe
equival
dose
ova
min
min
h
h
h
remov
sampl
cell
incub
trypan
blue
min
quench
extracellular
fitc
wash
three
time
prewarm
pb
cell
treat
trypsin
min
harvest
centrifug
analyz
flow
cytometri
bd
usa
determin
trace
amount
ova
tissu
ova
label
bolton
hunter
method
prior
prepar
formul
iova
subject
three
round
ultrafiltr
molecular
weight
cutoff
kda
remov
unbound
iodin
label
effici
radiochem
puriti
respect
intranas
group
rat
receiv
free
iova
iovanp
inp
intranas
radioact
dose
intramuscular
im
group
rat
inject
alumprecipit
iova
equival
dose
iova
left
thigh
rat
sacrif
four
rat
time
point
anesthesia
min
min
h
h
h
administr
blood
sampl
collect
heart
perfus
physiolog
salin
superfici
deep
cervic
lymph
node
brachial
lymph
node
axillari
lymph
node
heart
liver
spleen
lung
kidney
rat
care
excis
weight
subject
gamma
count
amount
ova
tissu
express
percentag
inject
dose
per
gram
tissu
area
concentrationtim
curv
auc
calcul
trapezoid
method
cervic
lymph
node
target
differ
formul
evalu
lymph
node
target
index
lnti
lntiauc
lymph
node
auc
blood
eight
femal
balbc
mice
hepe
group
ova
group
ovanp
group
npe
group
intranas
given
hepe
buffer
ova
solut
ovanp
npe
respect
three
time
intern
posit
group
im
group
receiv
three
intramuscular
inject
alumprecipit
ova
left
thigh
intern
dosag
ova
mous
blood
sampl
collect
orbit
venou
plexu
day
centrifug
min
sera
store
analysi
day
saliva
collect
filterpap
strip
dilut
ml
steril
pbsb
pb
contain
bsa
ph
vagin
wash
obtain
irrig
vagin
caviti
ml
steril
pbsb
nasal
wash
collect
flush
nasal
caviti
ml
steril
pbsb
nasopharyng
duct
nostril
lung
wash
collect
infus
ml
steril
pbsb
lung
trachea
draw
fluid
sever
time
collect
sampl
centrifug
min
supernat
store
analysi
nalt
isol
four
mice
group
accord
detail
procedur
report
previous
briefli
mice
sacrif
cervic
disloc
lower
jaw
tongu
remov
palat
care
isol
forcep
wash
complet
cultur
medium
supplement
fetal
bovin
serum
streptomycin
uiml
penicillin
gentamicin
fungizoneamphotericin
eight
time
cultur
complet
cultur
medium
plate
incub
h
cultur
medium
collect
centrifug
min
supernat
store
analysi
antibodi
level
serum
nasal
wash
determin
indirect
elisa
micropl
corn
usa
coat
per
well
ova
mm
sodium
carbon
ph
overnight
incub
micropl
wash
pbst
tween
ph
block
bsa
h
wash
micropl
pbst
per
well
serial
dilut
sampl
dilut
buffer
bsa
ad
incub
h
micropl
wash
per
well
hrpconjug
goat
antimous
igg
iga
dilut
buffer
ratio
ad
incub
h
wash
per
well
substrat
tmb
ad
incub
min
reaction
termin
h
absorb
measur
nm
use
multiskan
micropl
reader
thermo
scientif
usa
endpoint
titer
determin
xaxi
intercept
dilut
curv
observ
transport
ovanp
across
nasal
mucosa
rat
receiv
fitclabel
ova
ovanp
mgml
intranas
via
polyethylen
tube
attach
microsyring
min
min
h
h
h
administr
rat
sacrif
anesthesia
perfus
physiolog
salin
follow
paraformaldehyd
nasal
caviti
rat
care
excis
fix
h
decalcifi
edta
dehydr
sucros
solut
embed
oct
sakura
finetek
usa
section
freez
microtom
stain
dapi
section
observ
dmi
fluoresc
microscop
leica
germani
ovanp
carri
posit
charg
may
induc
toxic
nasal
caviti
due
electrostat
interact
cell
thu
nasal
toxic
ovanp
toward
rat
evalu
hematoxylin
eosin
h
e
stain
determin
toxic
indic
six
rat
group
receiv
ovanp
mgml
three
consecut
day
intranas
instil
hepe
buffer
use
neg
control
wv
deoxysodium
cholat
posit
control
rat
sacrif
h
last
administr
nasal
caviti
nasal
mucosa
isol
nasal
caviti
three
rat
group
fix
paraformaldehyd
decalcifi
edta
embed
paraffin
stain
h
e
observ
light
microscop
nasal
mucosa
homogen
three
time
volum
icecold
physiolog
salin
centrifug
min
supernat
use
determin
total
protein
gsh
accord
manufactur
instruct
content
gsh
express
nmolmg
protein
pgmg
protein
respect
polym
nanoparticl
posit
charg
tend
combin
erythrocyt
induc
hemolysi
blood
vessel
portion
ovanp
may
enter
blood
circul
nasal
administr
therefor
effect
ovanp
erythrocyt
studi
whole
blood
obtain
margin
ear
vein
new
zealand
white
rabbit
heparin
anticoagul
agent
centrifug
min
collect
blood
cell
wash
twice
pb
blood
cell
suspend
hepe
buffer
obtain
erythrocyt
suspens
differ
concentr
ovanp
incub
equal
volum
erythrocyt
suspens
h
hepe
buffer
use
neg
control
triton
posit
control
incub
blood
cell
remov
centrifug
min
supernat
mix
hcl
absorb
determin
nm
use
micropl
reader
percentag
hemolysi
calcul
follow
blank
absorb
blank
well
nm
data
express
deviat
comparison
differ
group
perform
oneway
anova
follow
studentnewmankeul
posthoc
test
pvalu
less
consid
signific
mani
method
use
achiev
conjug
ova
tmc
includ
chemic
crosslink
carbodiimid
crosslink
spdp
crosslink
howev
method
often
present
signific
problem
intramolecular
crosslink
weak
stabil
low
crosslink
effici
therefor
studi
thiol
maleimid
group
introduc
ova
tmc
respect
specif
quick
steadi
conjug
mild
reaction
condit
room
temperatur
magnet
stir
conjug
effici
ova
fitclabel
ova
np
respect
indic
full
use
ova
prepar
ovanp
vitro
uptak
ovanp
raw
cell
typic
immunocyt
macrophag
versatil
mani
respect
term
immun
respons
exampl
macrophag
phagocytos
digest
pathogen
present
antigen
stimul
lymphocyt
thu
murin
macrophag
line
raw
wide
use
predict
vivo
profil
nanoparticl
employ
evalu
cellular
uptak
ovanp
shown
fig
free
ova
could
hardli
taken
raw
cell
howev
nanoparticl
easili
recogn
foreign
substanc
taken
macrophag
timedepend
manner
interestingli
ovanp
group
show
significantli
higher
uptak
npe
group
min
h
h
h
p
may
caus
continu
releas
ova
npe
incub
period
biodistribut
ova
rat
administr
differ
formul
shown
fig
intranas
administ
ova
solut
nanoparticl
mainli
transport
superfici
deep
cervic
lymph
node
main
tissu
present
antigen
head
neck
region
wherea
small
amount
ova
transport
distant
lymph
node
brachial
lymph
node
axillari
lymph
node
intramuscularli
inject
ova
concentr
cervic
lymph
node
show
higher
distribut
tissu
liver
kidney
axillari
lymph
node
ovanp
npe
quickli
transport
superfici
cervic
lymph
node
concentr
nanoparticl
high
min
peak
min
free
ova
superfici
cervic
lymph
node
slowli
increas
h
auc
h
ovanp
group
significantli
higher
ova
npe
tabl
moreov
nasal
administ
formul
ova
show
higher
lnti
im
group
lnti
ovanp
group
time
im
group
demonstr
potenti
advantag
nasal
vaccin
prevent
respiratori
infecti
diseas
similarli
deep
cervic
lymph
node
ovanp
group
show
much
higher
auc
h
lnti
group
auc
h
ovanp
group
time
ova
npe
im
group
respect
addit
lnti
ovanp
group
time
ova
npe
im
group
respect
igg
level
mice
immun
shown
fig
alumprecipit
ova
induc
quick
strong
immun
respons
one
dose
im
inject
subsequ
two
dose
increas
igg
level
serum
demonstr
high
efficaci
alum
induct
system
immun
respons
nasal
immun
group
primari
dose
increas
igg
level
significantli
increas
level
indic
quicker
respons
antibodi
nanoparticl
serum
follow
two
booster
immun
significantli
increas
igg
level
ovanp
npe
group
especi
former
whose
igg
level
day
time
npe
im
group
respect
demonstr
high
level
system
immun
respons
nasal
immun
ovanp
addit
immun
respons
intramuscular
nasal
immun
predominantli
type
evidenc
much
higher
increas
antibodi
antibodi
fig
indic
humoralmedi
immun
respons
mice
mucos
immun
respons
secret
secretori
iga
siga
antibodi
import
prevent
infect
pathogen
via
mucos
surfac
nasal
lung
buccal
vagin
mucosa
brandtzaeg
indic
siga
exert
decis
role
protect
crossprotect
varieti
infecti
agent
demonstr
infect
model
knockout
mice
therefor
level
siga
secret
nasal
lung
buccal
vagin
mucosa
investig
three
immun
shown
fig
increas
siga
antibodi
observ
mucos
wash
im
group
confirm
presumpt
im
inject
alumprecipit
ova
induc
mucos
immun
respons
ova
alon
induc
strong
immun
respons
drop
nasal
caviti
due
low
immunogen
howev
ovanp
npe
significantli
increas
siga
level
mucosa
wash
furthermor
ovanp
induc
siga
level
time
higher
induc
npe
nasal
lung
buccal
vagin
wash
respect
clearli
demonstr
superior
former
activ
mucos
immun
respons
investig
role
nalt
secret
antibodi
nalt
isol
immun
mice
cultur
ex
vivo
studi
shown
fig
high
level
antibodi
secret
nalt
ex
vivo
cultur
h
siga
igg
level
ova
group
increas
compar
hepe
group
wherea
mani
antibodi
secret
ovanp
group
npe
group
im
group
igg
secret
siga
level
increas
trend
exhibit
antibodi
cultur
medium
nalt
similar
trend
observ
siga
level
nasal
wash
igg
level
serum
indic
nalt
particip
system
mucos
immun
respons
immun
shown
fig
green
fluoresc
observ
lamina
propria
nasal
mucosa
min
administr
ova
solut
suggest
rapid
transport
across
nasal
epithelium
green
fluoresc
scatter
lamina
propria
becam
stronger
min
disappear
h
compar
ova
solut
ovanp
group
show
stronger
durabl
green
fluoresc
lamina
propria
could
still
observ
h
green
fluoresc
ovanp
group
mainli
locat
surround
tissu
gland
suggest
nanoparticl
transport
across
epithelia
gland
bowman
gland
nasal
administr
ova
formul
may
also
transport
nasopharynx
nasal
cilia
movement
uptaken
nalt
shown
fig
sporad
green
fluoresc
observ
nalt
ova
solut
group
ovanp
group
min
nevertheless
distinct
green
fluoresc
observ
surfac
interior
nalt
min
especi
ovanp
group
green
fluoresc
ova
solut
group
decreas
h
disappear
h
wherea
fluoresc
signal
ovanp
group
remain
strong
h
could
still
observ
h
indic
higher
durabl
absorpt
ova
nalt
ovanp
ova
solut
two
concentr
ovanp
select
toxic
studi
low
concentr
mgml
consist
dosag
immun
studi
high
concentr
mgml
use
examin
whether
tmc
nanoparticl
toxic
nasal
mucosa
high
tmc
concentr
exampl
approxim
mgml
npe
immun
studi
repres
imag
rat
nasal
mucosa
shown
fig
larg
area
nasal
epithelium
cilia
damag
posit
group
demonstr
high
toxic
deoxysodium
cholat
toward
nasal
mucosa
nasal
cilia
bushi
regular
epithelium
intact
ovanp
group
similar
neg
group
indic
ovanp
mgml
mgml
affect
integr
nasal
cilia
epithelium
gsh
play
import
role
protect
reactiv
oxygen
speci
ro
content
tissu
reflect
degre
oxid
stress
typic
proinflammatori
cytokin
mediat
inflamm
may
serv
sensit
marker
acut
inflamm
respons
shown
fig
deoxysodium
cholat
caus
signific
decreas
gsh
increas
nasal
mucosa
ovanp
effect
concentr
gsh
indic
ovanp
induc
oxid
stress
inflammatori
reaction
nasal
administr
sever
time
treatment
triton
complet
hemolysi
erythrocyt
observ
red
diaphan
solut
obtain
shown
fig
ovanp
concentr
mgml
induc
slight
hemolysi
erythrocyt
inde
less
intern
standard
limit
spontan
hemolysi
indic
ovanp
affect
integr
function
erythrocyt
blood
circul
nasal
vaccin
induc
nasal
mucos
immun
distant
mucos
immun
well
system
immun
make
suitabl
prevent
respiratori
infecti
diseas
due
poor
immunogen
free
antigen
nanos
carrier
often
use
vaccin
adjuv
improv
immunogen
antigen
nasal
immun
commonli
antigen
encapsul
nanoparticl
howev
approach
sever
disadvantag
low
encapsul
effici
antigen
burst
releas
incomplet
releas
allow
fraction
antigen
contact
recogn
apc
nonid
immun
effect
exampl
studi
although
paramet
prepar
npe
optim
ova
could
encapsul
ova
npe
could
easili
leak
like
due
high
hydrophil
tmc
weak
electrostat
interact
tmc
ova
result
antigen
wast
small
amount
deliv
action
site
order
overcom
problem
ova
coval
conjug
surfac
quatern
chitosan
nanoparticl
nasal
immun
studi
cervic
lymph
node
main
lymphoid
tissu
pathogen
neck
head
region
solubl
particul
antigen
nasal
caviti
taken
apc
dendrit
cell
macrophag
lamina
propria
direct
cervic
lymph
node
activ
cell
b
cell
activ
lymphocyt
travel
mucos
effector
site
via
lymph
node
becom
matur
memori
effector
b
cell
amount
antigen
deliv
cervic
lymph
node
nasal
administr
determin
least
extent
mucos
system
immun
respons
therefor
focus
amount
ova
transport
cervic
lymph
node
administr
expect
intramuscularli
inject
ova
concentr
cervic
lymph
node
show
higher
distribut
liver
kidney
axillari
lymph
node
suggest
im
ova
fig
morpholog
nasal
mucosa
rat
intranas
administr
hepe
buffer
ovanp
mgml
b
ovanp
mgml
c
deoxysodium
cholat
three
time
cilia
indic
arrow
may
induc
weak
mucos
immun
respons
nasal
caviti
hand
intranas
ova
formul
mainli
transport
superfici
deep
cervic
lymph
node
might
activ
apc
result
high
level
system
mucos
ovaspecif
immun
respons
test
hypothesi
regard
pharmacokinet
result
system
mucos
immun
respons
induc
ova
formul
evalu
commonli
use
posit
control
im
inject
alumprecipit
ova
induc
quick
strong
immun
respons
one
dose
demonstr
high
efficaci
alum
activ
system
immun
respons
howev
alum
could
induc
mucos
immun
respons
consist
low
ova
level
im
inject
cervic
lymph
node
similar
report
primari
dose
nasal
immun
group
increas
igg
level
thu
two
dose
need
nasal
immun
activ
immun
system
interestingli
follow
three
nasal
immun
igg
level
ovanp
group
significantli
increas
even
higher
im
group
time
demonstr
high
level
system
immun
respons
follow
nasal
immun
ovanp
moreov
ovanp
induc
much
higher
siga
level
nasal
lung
buccal
vagin
wash
npe
especi
benefici
prevent
respiratori
infecti
diseas
worth
note
ovanp
induc
high
level
siga
vagin
mucosa
genit
tract
consid
lack
function
mucosaassoci
lymph
node
thu
intravagin
vaccin
alter
vagin
antibodi
respons
fortun
exist
common
mucos
immun
system
make
possibl
induc
mucos
immun
respons
genit
tract
via
nasal
immun
activ
immunocyt
nasal
mucosa
may
home
effector
site
mucosa
thu
induc
mucos
immun
respons
therefor
nasal
vaccin
antigenconjug
tmc
nanoparticl
may
conveni
use
method
fight
sexual
transmit
diseas
hiv
larg
volum
may
difficult
nanoparticl
permeat
nasal
epithelium
ovanp
penetr
nasal
mucosa
reach
cervic
lymph
node
studi
found
nanoparticl
transport
lamina
propria
gland
consist
report
previou
studi
strong
green
fluoresc
observ
bowman
gland
intranas
administr
wheat
germ
agglutininconjug
pegpla
nanoparticl
load
fluoresc
marker
addit
penetr
across
nasal
epithelia
nanoparticl
may
also
transport
nasopharynx
nasal
cilia
movement
contact
nalt
report
abund
cell
surfac
nalt
absorb
particul
studi
higher
durabl
absorpt
ova
nalt
ovanp
ova
solut
observ
suggest
ovanp
may
uptaken
cell
nalt
antigen
lamina
propria
nalt
drain
superfici
deep
cervic
lymph
node
receiv
affer
lymphat
drainag
nasal
caviti
nasolabi
region
activ
immun
respons
thu
larger
amount
ova
deriv
ovanp
ova
solut
npe
cervic
lymph
node
led
higher
level
immun
respons
addit
vaccin
safeti
nanoparticl
system
develop
herein
also
consid
toxic
studi
demonstr
ovanp
dose
littl
effect
nasal
mucosa
administ
nasal
three
time
erythrocyt
vitro
indic
ovanp
exhibit
good
biocompat
use
carrier
nasal
immun
studi
ovaconjug
ntrimethylaminoethylmethacryl
chitosan
nanoparticl
ovanp
nasal
immun
prepar
evalu
compar
ovaencapsul
nanoparticl
npe
ovanp
show
much
higher
encapsulationconjug
effici
higher
cellular
uptak
macrophag
vitro
effici
transport
cervic
lymph
node
vivo
result
much
stronger
system
mucos
immun
respons
nasal
administr
transport
mechan
studi
reveal
particul
antigen
easili
taken
nasal
epithelium
transport
cervic
lymph
node
compar
free
antigen
ovanp
induc
obviou
toxic
nasal
mucosa
hemolysi
conjug
antigen
surfac
nanoparticl
may
serv
effect
strategi
nasal
vaccin
especi
small
antigen
low
immunogen
